FORTRESS BIOTECH INC (FBIO)

US34960Q3074 - Common Stock

1.93  +0.17 (+9.66%)

After market: 1.9799 +0.05 (+2.59%)

News Image
3 days ago - Fortress Biotech, Inc.

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring...

News Image
4 days ago - BusinessInsider

FBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fortress Biotech (NASDAQ:FBIO) just reported results for the first quarter of 2...

News Image
4 days ago - InvestorPlace

FBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024

FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image
4 days ago - Fortress Biotech, Inc.

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially...

News Image
4 days ago - Journey Medical Corporation

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...

News Image
6 days ago - Journey Medical Corporation

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter...

News Image
6 days ago - Checkpoint Therapeutics, Inc

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted...

News Image
9 days ago - Checkpoint Therapeutics, Inc

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted...

News Image
12 days ago - Journey Medical Corporation

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET...

News Image
18 days ago - Journey Medical Corporation

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...

News Image
24 days ago - Journey Medical Corporation

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...

News Image
a month ago - InvestorPlace

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

News Image
2 months ago - InvestorPlace

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023

FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image
2 months ago - BusinessInsider

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fortress Biotech (NASDAQ:FBIO) just reported results for the fourth quarter of ...

News Image
2 months ago - Fortress Biotech, Inc.

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18...

News Image
2 months ago - Checkpoint Therapeutics, Inc

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and...

News Image
2 months ago - Journey Medical Corporation

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 ...

News Image
2 months ago - Journey Medical Corporation

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024...

News Image
2 months ago - Journey Medical Corporation

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET...

News Image
2 months ago - Journey Medical Corporation

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical...

News Image
2 months ago - Fortress Biotech, Inc.

Fortress Biotech to Participate in 36th Annual ROTH Conference

MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on...

News Image
2 months ago - Journey Medical Corporation

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that...

News Image
3 months ago - Fortress Biotech, Inc.

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for...

News Image
4 months ago - TheNewswire.com

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

New York, Feb 2, 2024 - (Plato Data via 500NewsWire) -- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang.

News Image
5 months ago - Seeking Alpha

Journey Medical submits NDA for DFD-29 for rosacea (NASDAQ:DERM)

Journey Medical (FBIO) said it has submitted a New Drug Application for its rosacea treatment DFD-29. The product is being developed with Dr. Reddy's (RDY). Read more here.

News Image
5 months ago - Journey Medical Corporation

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea...

News Image
5 months ago - Fortress Biotech, Inc.

Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused...

News Image
5 months ago - Journey Medical Corporation

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Provides additional capital for general corporate purposes including funding to support the potential launch of DFD-29...